DE68917677T2 - Vorrichtung für kontrollierte Wirkstoffabgabe mit einem undurchlässigen Ueberzug und Austrittsöffnung für die Wirkstoffabgabe. - Google Patents
Vorrichtung für kontrollierte Wirkstoffabgabe mit einem undurchlässigen Ueberzug und Austrittsöffnung für die Wirkstoffabgabe.Info
- Publication number
- DE68917677T2 DE68917677T2 DE68917677T DE68917677T DE68917677T2 DE 68917677 T2 DE68917677 T2 DE 68917677T2 DE 68917677 T DE68917677 T DE 68917677T DE 68917677 T DE68917677 T DE 68917677T DE 68917677 T2 DE68917677 T2 DE 68917677T2
- Authority
- DE
- Germany
- Prior art keywords
- drug delivery
- outlet
- impermeable coating
- delivery device
- controlled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Coating Apparatus (AREA)
- Paints Or Removers (AREA)
- General Preparation And Processing Of Foods (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888820353A GB8820353D0 (en) | 1988-08-26 | 1988-08-26 | Controlled release tablet |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68917677D1 DE68917677D1 (de) | 1994-09-29 |
DE68917677T2 true DE68917677T2 (de) | 1994-12-22 |
Family
ID=10642806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68917677T Expired - Lifetime DE68917677T2 (de) | 1988-08-26 | 1989-08-25 | Vorrichtung für kontrollierte Wirkstoffabgabe mit einem undurchlässigen Ueberzug und Austrittsöffnung für die Wirkstoffabgabe. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5004614A (de) |
EP (1) | EP0365123B1 (de) |
AT (1) | ATE110262T1 (de) |
AU (1) | AU4218489A (de) |
CA (1) | CA1339079C (de) |
DE (1) | DE68917677T2 (de) |
ES (1) | ES2058543T3 (de) |
GB (2) | GB8820353D0 (de) |
IE (1) | IE63764B1 (de) |
WO (1) | WO1990001925A1 (de) |
Families Citing this family (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366738A (en) * | 1982-07-29 | 1994-11-22 | Merck & Co., Inc. | Controlled release drug dispersion delivery device |
US5178866A (en) * | 1990-03-23 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug to the intestine |
EP0542915A1 (de) * | 1990-08-09 | 1993-05-26 | Endocon, Inc. | Mehrfaches arzneimittel abgabesystem |
AU651654B2 (en) * | 1992-01-14 | 1994-07-28 | Endo Pharmaceuticals Solutions Inc. | Manufacture of water-swellable hydrophilic articles and drug delivery devices |
US5266325A (en) * | 1990-09-28 | 1993-11-30 | Hydro Med Science Division Of National Patent Development Corp. | Preparation of homogeneous hydrogel copolymers |
US5922342A (en) * | 1990-10-01 | 1999-07-13 | Pharmacia & Upjohn Company | Lateral edge coated controlled release pharmaceutical compositions |
AU655596B2 (en) * | 1990-10-01 | 1995-01-05 | Pharmacia & Upjohn Company | Lateral edge coated controlled release pharmaceutical compositions |
WO1992011845A1 (en) * | 1991-01-03 | 1992-07-23 | Glaxo Canada Inc. | Method for production of solid pharmaceutical preparation |
US5543154A (en) * | 1991-12-27 | 1996-08-06 | Merck & Co., Inc. | Controlled release nifedipine delivery device |
AU3917393A (en) * | 1992-05-12 | 1993-12-13 | Church & Dwight Company, Inc. | Fungicide compositions |
AU3801793A (en) * | 1992-05-12 | 1993-12-13 | Church & Dwight Company, Inc. | Herbicide compositions |
WO1993022915A1 (en) * | 1992-05-12 | 1993-11-25 | Church & Dwight Company, Inc. | Insecticide compositions |
DE69302577T2 (de) * | 1993-07-12 | 1996-09-12 | Nestle Sa | Behälterverschluss mit Sicherheitsring |
DE4431653C2 (de) | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung |
US6342570B1 (en) * | 1994-11-14 | 2002-01-29 | Novartis Ag | Cross-linkable copolymers and hydrogels |
US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
US5830884A (en) * | 1995-01-18 | 1998-11-03 | National Starch And Chemical Investment Holding Corporation | Pharmaceutical products containing thermally-inhibited starches |
US20060280774A1 (en) * | 1995-06-02 | 2006-12-14 | Allergan, Inc. | Compositions and methods for treating glaucoma |
US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
US5733270A (en) * | 1995-06-07 | 1998-03-31 | Baxter International Inc. | Method and device for precise release of an antimicrobial agent |
DK0859612T3 (da) * | 1995-09-21 | 2003-09-22 | Pharma Pass Ii Llc | Farmaceutisk sammensætning indeholdende en syre-labil omeprazol og fremgangsmåde til fremstilling deraf |
US6361796B1 (en) * | 1996-10-25 | 2002-03-26 | Shire Laboratories, Inc. | Soluble form osmotic dose delivery system |
DE19728249C2 (de) * | 1997-07-02 | 2001-05-03 | Georgios Pandalis | Produkt aus einem Kern und mindestens einer ein Naturharz enthaltenden Umhüllung, Steckkapsel, Verfahren zur Herstellung einer Filmtablette, Weichkapsel, Steckkapsel und Verwendung von Naturharzen |
US6110500A (en) * | 1998-03-25 | 2000-08-29 | Temple University | Coated tablet with long term parabolic and zero-order release kinetics |
US20040102486A1 (en) * | 1998-11-12 | 2004-05-27 | Smithkline Beecham Corporation | Novel method of treatment |
US20030153607A1 (en) * | 1998-11-12 | 2003-08-14 | Smithkline Beecham P.L.C. | Novel composition and use |
US20040081697A1 (en) * | 1998-11-12 | 2004-04-29 | Smithkline Beecham P.L.C. | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
US6331313B1 (en) | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
US6497157B1 (en) * | 1999-11-29 | 2002-12-24 | Distek, Inc. | Intrinsic dissolution apparatus with stationary sample holder |
US20060153914A1 (en) * | 1999-12-10 | 2006-07-13 | Biovail Laboratories International S.R.L. | Chronotherapeutic diltiazem formulations and the administration thereof |
US7108866B1 (en) | 1999-12-10 | 2006-09-19 | Biovall Laboratories International Srl | Chronotherapeutic diltiazem formulations and the administration thereof |
US6352721B1 (en) * | 2000-01-14 | 2002-03-05 | Osmotica Corp. | Combined diffusion/osmotic pumping drug delivery system |
US6569152B2 (en) | 2000-03-21 | 2003-05-27 | Farrington Pharmaceuticals, Llc | Sustained release delivery systems for solutes |
US6726918B1 (en) | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
US20030086972A1 (en) * | 2000-08-09 | 2003-05-08 | Appel Leah E. | Hydrogel-driven drug dosage form |
GB0027471D0 (en) * | 2000-11-08 | 2000-12-27 | Smithkline Beecham Plc | Processes |
US6699493B2 (en) | 2000-11-29 | 2004-03-02 | Oculex Pharmaceuticals, Inc. | Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
US6544557B2 (en) * | 2001-01-09 | 2003-04-08 | Pan Pharmaceutical Limited | Effervescent tablet compositions |
DE60219478T2 (de) * | 2001-07-06 | 2008-01-03 | Endo Pharmaceuticals Inc. | Orale gabe von 6-hydroxy-oxymorphon als analgetikum |
US7083578B2 (en) * | 2001-07-12 | 2006-08-01 | Given Imaging Ltd. | Device and method for examining a body lumen |
GB0117618D0 (en) * | 2001-07-19 | 2001-09-12 | Phoqus Ltd | Pharmaceutical dosage form |
GB0120835D0 (en) * | 2001-08-28 | 2001-10-17 | Smithkline Beecham Plc | Process |
US7850758B2 (en) * | 2006-01-17 | 2010-12-14 | The Andersons, Inc. | Safened insecticide matter |
ATE376826T1 (de) * | 2001-09-28 | 2007-11-15 | Mcneil Ppc Inc | Darreichungsformen zur modifizierten freisetzung |
US20040253312A1 (en) * | 2001-09-28 | 2004-12-16 | Sowden Harry S. | Immediate release dosage form comprising shell having openings therein |
US8101209B2 (en) * | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
MY139719A (en) * | 2002-02-12 | 2009-10-30 | Glaxo Group Ltd | Oral dosage form for controlled drug release |
GB0203296D0 (en) * | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
MXPA04008903A (es) * | 2002-03-11 | 2004-11-26 | Alcon Inc | Sistema de suministro de farmaco implantable. |
US8637512B2 (en) * | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
KR100882707B1 (ko) * | 2002-07-29 | 2009-02-06 | 글락소 그룹 리미티드 | 라모트리진을 포함하는 서방형 제제 |
US20050048099A1 (en) | 2003-01-09 | 2005-03-03 | Allergan, Inc. | Ocular implant made by a double extrusion process |
US7037521B2 (en) * | 2003-03-28 | 2006-05-02 | Bausch & Lomb Incorporated | Using a laser for cutting a hole in a capsule for controlled drug delivery |
EP1615626B1 (de) * | 2003-04-24 | 2009-10-14 | Jagotec Ag | Tablette mit gefärbtem kern |
CA2529984C (en) | 2003-06-26 | 2012-09-25 | Isa Odidi | Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
UY28457A1 (es) * | 2003-08-07 | 2005-03-31 | Sb Pharmco Inc | Nueva composición |
GB0318824D0 (en) * | 2003-08-11 | 2003-09-10 | Glaxo Group Ltd | Novel composition |
US20050175695A1 (en) * | 2003-11-25 | 2005-08-11 | Catherine Castan | Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
US20050169994A1 (en) * | 2003-11-25 | 2005-08-04 | Burke Matthew D. | Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
US7879354B2 (en) | 2004-01-13 | 2011-02-01 | Mcneil-Ppc, Inc. | Rapidly disintegrating gelatinous coated tablets |
US8067029B2 (en) | 2004-01-13 | 2011-11-29 | Mcneil-Ppc, Inc. | Rapidly disintegrating gelatinous coated tablets |
WO2005074976A1 (en) * | 2004-02-09 | 2005-08-18 | Transfert Plus Société En Commandite | Composition comprising polymeric material and uses thereof |
US20050244469A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Extended therapeutic effect ocular implant treatments |
EP1773293B1 (de) | 2004-06-17 | 2015-04-15 | Endo Pharmaceuticals Solutions Inc. | Zusammensetzungen und verfahren zur behandlung von zentraler vorzeitiger pubertät |
US8394409B2 (en) * | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
CA2491665A1 (fr) * | 2004-12-24 | 2006-06-24 | Louis Cartilier | Formulation de comprime pour liberation soutenue de principe actif |
CA2596933A1 (en) * | 2005-02-03 | 2006-08-10 | Duramed Pharmaceuticals, Inc. | Devices for delivering agents to a vaginal tract |
US7905181B2 (en) * | 2005-02-05 | 2011-03-15 | Ciesiun Paul M | Bioluminescent paintball |
US7759312B2 (en) * | 2005-03-11 | 2010-07-20 | Endo Pharmaceuticals Solutions Inc. | Delivery of dry formulations of octreotide |
EP2457564A1 (de) * | 2005-03-11 | 2012-05-30 | Endo Pharmaceuticals Solutions Inc. | Octreotid-Formulierungen mit kontrollierter Freisetzung |
US20060228487A1 (en) * | 2005-04-11 | 2006-10-12 | J. Rettenmaier & Söehne GmbH + Co. KG | Methods of combining active agents with augmented microcrystalline cellulose |
US8673352B2 (en) * | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
US20070009573A1 (en) * | 2005-07-07 | 2007-01-11 | L N K International | Method of forming immediate release dosage form |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
US20070178138A1 (en) * | 2006-02-01 | 2007-08-02 | Allergan, Inc. | Biodegradable non-opthalmic implants and related methods |
US20090304768A1 (en) * | 2006-02-15 | 2009-12-10 | Intec Pharma Ltd | Gastro-Retentive System for the Delivery of Macromolecules |
JP5457830B2 (ja) * | 2006-04-03 | 2014-04-02 | オディディ,イサ | オルガノゾル被膜を含む制御放出送達デバイス |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
US8802128B2 (en) * | 2006-06-23 | 2014-08-12 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US20070298073A1 (en) * | 2006-06-23 | 2007-12-27 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
MY149863A (en) | 2006-08-03 | 2013-10-31 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of rheumatoid disease |
EP1916006A1 (de) * | 2006-10-19 | 2008-04-30 | Albert Schömig | Wachs oder Harz beschichtetes Implantat |
EP1913960A1 (de) * | 2006-10-19 | 2008-04-23 | Albert Schömig | Beschichtetes Implantat |
MX2009011641A (es) * | 2007-04-27 | 2010-03-04 | Endo Pharmaceuticals Solutions | Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos. |
US20090074866A1 (en) * | 2007-09-17 | 2009-03-19 | Jen-Chi Chen | Dip coated compositions containing copolymer of polyvinyl alcohol and polyethylene glycol and a gum |
US20090196924A1 (en) * | 2008-02-04 | 2009-08-06 | Pramod Kharwade | Controlled-release lamotrigine formulations |
US20090312627A1 (en) * | 2008-06-16 | 2009-12-17 | Matott Laura A | Radio-labeled ingestible capsule |
JP5622725B2 (ja) | 2008-06-25 | 2014-11-12 | エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド.Endo Pharmaceuticals Solutionsinc. | エキセナチド及び他のポリペプチド類の持続的送達 |
WO2009158415A1 (en) * | 2008-06-25 | 2009-12-30 | Endo Pharmaceuticals Solutions Inc. | Octreotide implant having a release agent |
US20100323016A1 (en) * | 2008-07-18 | 2010-12-23 | Biljana Nadjsombati | Modified release formulation and methods of use |
US20100323015A1 (en) * | 2008-07-18 | 2010-12-23 | Biljana Nadjsombati | Modified release formulation and methods of use |
KR20110052641A (ko) * | 2008-07-18 | 2011-05-18 | 베일언트 파마슈티컬스 인터내셔널 | 변형 방출형 제형 및 이의 이용 방법 |
AU2010207740B2 (en) * | 2009-01-26 | 2016-06-16 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of asthma |
DK2400950T3 (da) | 2009-02-26 | 2019-07-29 | Glaxo Group Ltd | Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
EP2564836A1 (de) | 2009-05-20 | 2013-03-06 | Ranbaxy Laboratories Limited | Lamotriginformulierungen mit gesteuerter Freisetzung |
US20110052686A1 (en) | 2009-09-03 | 2011-03-03 | Ranbaxy Laboratories Limited | Modified release lamotrigine tablets |
US8187617B2 (en) * | 2009-09-11 | 2012-05-29 | William Wayne Howard | Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
WO2011079050A2 (en) | 2009-12-23 | 2011-06-30 | The Smart Pill Corporation | Method of evaluating constipation using an ingestible capsule |
SG181827A1 (en) | 2010-01-20 | 2012-07-30 | Glaxo Group Ltd | Novel retigabine composition |
USPP22279P2 (en) | 2010-09-02 | 2011-11-29 | Floranova Service Corp | Ipomoea plant named ‘IPOSGLGRE’ |
EP2651399A2 (de) | 2010-12-13 | 2013-10-23 | Purdue Pharma LP | Retard-darreichungsformen |
US9351924B2 (en) * | 2011-03-11 | 2016-05-31 | Snu R&Db Foundation | Drug delivery system including laminated structure |
CN103987378B (zh) * | 2011-09-09 | 2016-12-14 | 阿克西亚制药有限责任公司 | 硅氧烷涂覆的植入物 |
CN109311773A (zh) * | 2016-03-23 | 2019-02-05 | 先锋国际良种公司 | 用于提高作物产量的农业系统、组合物和方法 |
AU2018341349A1 (en) | 2017-09-27 | 2020-04-09 | E. I. Du Pont De Nemours And Company | Soil application of crop protection agents |
WO2020234716A1 (en) | 2019-05-17 | 2020-11-26 | Glaxosmithkline Intellectual Property Development Limited | Matrix composition comprising (s)-5-benzyl-n-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4h-1,2,4-triazole-3-carboxamide |
CN115737580B (zh) * | 2022-12-06 | 2024-04-30 | 海南皇隆制药股份有限公司 | 一种提高降血糖效率的伏格列波糖片及其制备方法 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB972128A (en) * | 1960-01-21 | 1964-10-07 | Wellcome Found | Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets |
GB1022171A (en) * | 1961-06-15 | 1966-03-09 | Wellcome Found | Prolonged release oral pharmaceutical tablets and their manufacture |
FR7805M (de) * | 1964-04-09 | 1970-05-20 | ||
NL175029C (nl) * | 1970-12-23 | 1984-09-17 | Boehringer Sohn Ingelheim | Depotdragee, die bekleed is met een onoplosbare en onverteerbare schaal, die op een of meer plaatsen een uitsparing vertoont. |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
CA1024891A (en) * | 1972-06-06 | 1978-01-24 | Boehringer Ingelheim G.M.B.H. | Coated retard tablets with exponential release of active ingredient |
US4036227A (en) * | 1973-04-25 | 1977-07-19 | Alza Corporation | Osmotic releasing device having a plurality of release rate patterns |
US3924622A (en) * | 1973-10-11 | 1975-12-09 | Mead Johnson & Co | Zero-order release method |
DE2438965A1 (de) * | 1974-08-14 | 1976-02-26 | Hoechst Ag | Basisch substituierte 3,4-dihydro2h-isochinolin-1-thione und verfahren zu ihrer herstellung |
US4142526A (en) * | 1974-12-23 | 1979-03-06 | Alza Corporation | Osmotic releasing system with means for changing release therefrom |
US3952741A (en) * | 1975-01-09 | 1976-04-27 | Bend Research Inc. | Controlled release delivery system by an osmotic bursting mechanism |
US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4058122A (en) * | 1976-02-02 | 1977-11-15 | Alza Corporation | Osmotic system with laminated wall formed of different materials |
US4014334A (en) * | 1976-02-02 | 1977-03-29 | Alza Corporation | Laminated osmotic system for dispensing beneficial agent |
US4111203A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system with means for improving delivery kinetics of system |
US4218433A (en) * | 1977-03-03 | 1980-08-19 | Nippon Kayaku Kabushiki Kaisha | Constant-rate eluting tablet and method of producing same |
US4160452A (en) * | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
US4271113A (en) * | 1978-04-17 | 1981-06-02 | Alza Corporation | Process for forming a passageway in an osmotic device |
US4217898A (en) * | 1978-10-23 | 1980-08-19 | Alza Corporation | System with microporous reservoir having surface for diffusional delivery of agent |
US4235236A (en) * | 1979-02-12 | 1980-11-25 | Alza Corporation | Device for dispensing drug by combined diffusional and osmotic operations |
DE2922522A1 (de) * | 1979-06-01 | 1980-12-04 | Dudzik Joachim | Tablette |
US4449983A (en) * | 1982-03-22 | 1984-05-22 | Alza Corporation | Simultaneous delivery of two drugs from unit delivery device |
US4519801A (en) * | 1982-07-12 | 1985-05-28 | Alza Corporation | Osmotic device with wall comprising cellulose ether and permeability enhancer |
US4612008A (en) * | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
GB8319766D0 (en) * | 1983-07-22 | 1983-08-24 | Graham N B | Controlled release device |
GB8322007D0 (en) * | 1983-08-16 | 1983-09-21 | Wellcome Found | Pharmaceutical delivery system |
US4610686A (en) * | 1983-11-02 | 1986-09-09 | Alza Corporation | Controlled delivery of haloperidol by an osmotic delivery system |
GB8403138D0 (en) * | 1984-02-07 | 1984-03-14 | Graham N B | Sustained release of active ingredient |
US4601893A (en) * | 1984-02-08 | 1986-07-22 | Pfizer Inc. | Laminate device for controlled and prolonged release of substances to an ambient environment and method of use |
US4772474A (en) * | 1985-08-09 | 1988-09-20 | Alza Corporation | Dispenser with internal arrangement of lamina means for dispensing beneficial agent |
US4609374A (en) * | 1985-04-22 | 1986-09-02 | Alza Corporation | Osmotic device comprising means for governing initial time of agent release therefrom |
US4624847A (en) * | 1985-04-22 | 1986-11-25 | Alza Corporation | Drug delivery device for programmed delivery of beneficial drug |
US4693886A (en) * | 1985-04-22 | 1987-09-15 | Alza Corporation | Osmotic device with inert core |
US4663147A (en) * | 1985-09-03 | 1987-05-05 | International Minerals & Chemical Corp. | Disc-like sustained release formulation |
IT1188212B (it) * | 1985-12-20 | 1988-01-07 | Paolo Colombo | Sistema per il rilascio a velocita' controllata di sostanze attive |
US4857330A (en) * | 1986-04-17 | 1989-08-15 | Alza Corporation | Chlorpheniramine therapy |
FR2599624B2 (fr) * | 1986-06-09 | 1990-06-29 | Virbac | Dispositif a liberation programmee |
US4816262A (en) * | 1986-08-28 | 1989-03-28 | Universite De Montreal | Controlled release tablet |
US4803076A (en) * | 1986-09-04 | 1989-02-07 | Pfizer Inc. | Controlled release device for an active substance |
US4830860A (en) * | 1986-10-30 | 1989-05-16 | Pfizer Inc. | Stressed polymeric device for controlled release of a substance to an ambient environment |
US4792448A (en) * | 1987-06-11 | 1988-12-20 | Pfizer Inc. | Generic zero order controlled drug delivery system |
US4814183A (en) * | 1987-08-31 | 1989-03-21 | Merck & Co., Inc. | Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins |
-
1988
- 1988-08-26 GB GB888820353A patent/GB8820353D0/en active Pending
-
1989
- 1989-08-25 IE IE273689A patent/IE63764B1/en not_active IP Right Cessation
- 1989-08-25 ES ES89308645T patent/ES2058543T3/es not_active Expired - Lifetime
- 1989-08-25 DE DE68917677T patent/DE68917677T2/de not_active Expired - Lifetime
- 1989-08-25 AT AT89308645T patent/ATE110262T1/de not_active IP Right Cessation
- 1989-08-25 AU AU42184/89A patent/AU4218489A/en not_active Abandoned
- 1989-08-25 GB GB8919448A patent/GB2222948B/en not_active Expired - Lifetime
- 1989-08-25 CA CA000609411A patent/CA1339079C/en not_active Expired - Lifetime
- 1989-08-25 EP EP89308645A patent/EP0365123B1/de not_active Expired - Lifetime
- 1989-08-25 US US07/398,632 patent/US5004614A/en not_active Expired - Lifetime
- 1989-08-25 WO PCT/GB1989/000997 patent/WO1990001925A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
IE63764B1 (en) | 1995-06-14 |
EP0365123A1 (de) | 1990-04-25 |
GB8919448D0 (en) | 1989-10-11 |
IE892736L (en) | 1990-02-26 |
GB2222948A (en) | 1990-03-28 |
GB2222948B (en) | 1993-02-03 |
ATE110262T1 (de) | 1994-09-15 |
CA1339079C (en) | 1997-07-29 |
US5004614A (en) | 1991-04-02 |
GB8820353D0 (en) | 1988-09-28 |
DE68917677D1 (de) | 1994-09-29 |
ES2058543T3 (es) | 1994-11-01 |
WO1990001925A1 (en) | 1990-03-08 |
AU4218489A (en) | 1990-03-23 |
EP0365123B1 (de) | 1994-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68917677D1 (de) | Vorrichtung für kontrollierte Wirkstoffabgabe mit einem undurchlässigen Ueberzug und Austrittsöffnung für die Wirkstoffabgabe. | |
IT8667646A0 (it) | Dispositivo erogatore per la sommi nistrazione con portata di erogazione controllata di un agente terapeutico | |
SE8601791D0 (sv) | Osmotisk anordning med sjelvforseglande passage | |
EP0347024A3 (en) | Aqueous emulsion coating for pharmaceutical dosage form | |
CA2104699A1 (en) | Sustained release drug delivery devices | |
ATE63059T1 (de) | Vorrichtung mit zwei schichten zur freisetzung von arzneimitteln. | |
CH423204A (fr) | Procédé et dispositif pour ébavurer le col d'un corps creux en matière plastique | |
FR2292489A1 (fr) | Dispositif pour l'application prolongee d'un medicament sur la peau d'un animal | |
DE69204009D1 (de) | Vorrichtung für die pulsierende Abgabe einer Bewässerungsflüssigkeit, und Bewässerungssysteme mit einer solchen Vorrichtung. | |
ATE99155T1 (de) | Vorrichtung zur injektionsfreien verabreichung und dosierung einer fluessigkeit. | |
BE892525A (fr) | Appareil d'atomisation et de distribution de matieres de revetement | |
IL88123A0 (en) | Device for the pulsed delivery of an irrigation liquid,and irrigation facilities incorporating the same device | |
ATE89720T1 (de) | Wasserdisperierbare gemfibrozilhaltige mittel. | |
DE58909724D1 (de) | Verwendung einer Vorrichtung mit einem Wirkstoffreservoir für gesteuerte Wirkstoffabgabe | |
BR8600511A (pt) | Processo e dispositivo para a medicao da massa de um agente fluido | |
EP0324441A3 (de) | Einrichtung zum dosierten Auftragen von Klebstoff | |
FR1475911A (fr) | Procédé et dispositif pour la fabrication d'un corps creux en matière thermoplatique et article en résultant | |
NL7806566A (nl) | Werkwijze en inrichting voor het regelen van de volumens van primaire en secondaire lucht die gemengd in een ruimte met geregelde toestand stromen. | |
EP0271785A3 (en) | Dosing device for setting the liquid flow into or out of a living body | |
BR9306162A (pt) | Dispositivo para a liberação de substância no rúmen de um animal | |
DE69002497T2 (de) | Vorrichtung zur Messung der Lage einer beweglichen Einrichtung längs einer Geraden sowie deren Anwendung bei Robotern. | |
GB2142945B (en) | Device for the dosage and injection of a small quantity of liquid into the splicing air of a pneumatic yarn splicing device | |
BE895805A (fr) | Nouvel heptadecapeptide a effet de liberation d'hormone de croissance et medicament le contenant | |
FR2613942B1 (fr) | Dispositif pour liberer lentement des substances chimiques, notamment dans des cavites du corps d'un animal | |
FR2584931B1 (fr) | Dispositif doseur permettant l'application de medicaments sur la peau et les muqueuses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: SB PHARMCO PUERTO RICO INC., CIDRA, P.R., US |